Myriad RBM Teams with Spinal Muscular Atrophy Foundation on Protein Marker Panel
April 06, 2012
Myriad RBM Teams with Spinal Muscular Atrophy Foundation on Protein Marker Panel
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Myriad RBM Inks Deal with Bio-Rad to Develop and Sell Immunoassay Kits
July 27, 2012 / ProteoMonitor - Myriad RBM Collaborating with Max Planck on Test for Early Detection of Colon Cancer
May 11, 2012 / ProteoMonitor - Somalogic Teams with HUNT for 2,000-Patient Validation Study of Cardiovascular Biomarkers
April 13, 2012 / ProteoMonitor - Analysis of Alzheimer's Plasma Proteome Dataset Highlights Benefits of Longitudinal Data
April 6, 2012 / ProteoMonitor - Myriad to Enter Proteomics Market with $80M Purchase of Rules-Based Medicine
April 29, 2011 / ProteoMonitor